Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vaccines

Free Subscription 06.10.2025 1 Ann Intern Med 1 Arch Virol 3 BMJ 1 Clin Infect Dis 1 J Immunol 2 J Virol 4 JAMA 3 MMWR Morb Mortal Wkly Rep 1 Pediatr Infect Dis J 1 PLoS Comput Biol 7 PLoS One 4 Proc Natl Acad Sci U S A 20 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. ANDREWS RA, Erickson SM, Goldman JM, Moyer DV, et al
   Deja Flu All Over Again: The Risk for Overwhelm of the U.S. Health Care System by Vaccine-Preventable and Modifiable Diseases.
   Ann Intern Med. 2025 Sep 30. doi: 10.7326/ANNALS-25-03999.
   PubMed        
   
   

   
   Arch Virol

2. CUI X, Wang S, Han Q, Jin N, et al
   Molecular characterization of infectious laryngotracheitis virus in China and host transcriptomic responses to immunization with a live attenuated vaccine.
   Arch Virol. 2025;170:216.
   PubMed         Abstract available
   
   

   
   BMJ

3. YANG YT
   Rethinking the narrative on vaccine policy and public trust.
   BMJ. 2025;390:r1952.
   PubMed        
   
   
4. DYER O
   Covid vaccines: How is policy changing in the US and UK?
   BMJ. 2025;390:r2040.
   PubMed        
   
   
5. LANG K
   Trump's claims on Tylenol (paracetamol), vaccines, and autism-what's the truth?
   BMJ. 2025;390:r2025.
   PubMed        
   
   

   
   Clin Infect Dis

6. CARAZO S, Phimmasone J, Skowronski DM, Giguere K, et al
   Effectiveness of COVID-19 vaccination and prior infections to reduce long COVID risk during the pre-Omicron and Omicron periods.
   Clin Infect Dis. 2025 Sep 29:ciaf549. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Immunol

7. KRUEGER PD, Osum KC, Fife BT, Jenkins MK, et al
   Foreign epitope-specific regulatory T cells respond robustly to vaccination and limit Th1 differentiation by conventional T cells specific for the same epitope.
   J Immunol. 2025 Sep 27:vkaf254. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Virol

8. PAN Z, Jiang L, Chen Y, Peng H, et al
   Adjuvant-dependent protection of SARS-CoV-2 spike vaccines: comparative immunogenicity of human-applicable formulations.
   J Virol. 2025 Oct 3:e0109925. doi: 10.1128/jvi.01099.
   PubMed         Abstract available
   
   
9. SUN L, Huang M, Feng S, Zhang W, et al
   Developing an eVLP mRNA vaccine for respiratory syncytial virus with enhanced pre-fusion targeting humoral responses.
   J Virol. 2025 Sep 30:e0120925. doi: 10.1128/jvi.01209.
   PubMed         Abstract available
   
   

   
   JAMA

10. LOTSCHER J, Walti CS, Heller S, Hengy Linder F, et al
    Respiratory Syncytial Virus Vaccination in Adult Allogeneic Hematopoietic Cell Transplant Recipients.
    JAMA. 2025 Oct 2:e2516744. doi: 10.1001/jama.2025.16744.
    PubMed        
    
    
11. VERMUND SH
    Potential Repercussions of Eliminating Mandatory Vaccination in Florida.
    JAMA. 2025 Oct 1. doi: 10.1001/jama.2025.19510.
    PubMed        
    
    
12. NAVIN MC, Ross LF
    America's Vaccine Policy Whiplash-Finding the Way Forward.
    JAMA. 2025 Oct 1. doi: 10.1001/jama.2025.19088.
    PubMed        
    
    
13. ANDERER S
    Updated COVID-19 Vaccine Generates Strong Immune Response.
    JAMA. 2025 Sep 26. doi: 10.1001/jama.2025.13887.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

14. FAZAL A, Harker EJ, Neelam V, Olson SM, et al
    Pediatric Influenza-Associated Encephalopathy and Acute Necrotizing Encephalopathy - United States, 2024-25 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2025;74:556-564.
    PubMed         Abstract available
    
    
15. REINHART K, Huang S, Kniss K, Reed C, et al
    Influenza-Associated Pediatric Deaths - United States, 2024-25 Influenza Season.
    MMWR Morb Mortal Wkly Rep. 2025;74:565-569.
    PubMed         Abstract available
    
    
16. RUSS S, Nogareda F, Regan AK, Benedetti E, et al
    Interim Effectiveness Estimates of 2025 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Outpatient and Hospitalized Illness - Eight Southern Hemisphere Countries, March-September 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:570-578.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

17. HOMINAL A, Gualtieri R, Lemaitre B, Posfay-Barbe KM, et al
    Vaccine Immunity Against Pneumococcus in Children With Cochlear Implants.
    Pediatr Infect Dis J. 2025 Sep 26. doi: 10.1097/INF.0000000000004999.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

18. 
    Correction: Design of field trials for the evaluation of transmissible vaccines in animal populations.
    PLoS Comput Biol. 2025;21:e1013530.
    PubMed         Abstract available
    
    

    
    PLoS One

19. TOGEL J, Kuhbandner C
    COVID-19 vaccinations among German university students: The role of fear of COVID-19 and risk assessment.
    PLoS One. 2025;20:e0333082.
    PubMed         Abstract available
    
    
20. CHEMAITELLY H, Ayoub HH, Coyle P, Tang P, et al
    Evaluating the cost-effectiveness of COVID-19 mRNA primary-series vaccination in Qatar: An integrated epidemiological and economic analysis.
    PLoS One. 2025;20:e0331654.
    PubMed         Abstract available
    
    
21. FORTUNATO P, Lombini A
    Behind political affiliation: How moral values, identity politics, and party loyalty have affected COVID-19 vaccination.
    PLoS One. 2025;20:e0330881.
    PubMed         Abstract available
    
    
22. JORDAN S, Bottger SJ, Zinn S
    The persuasiveness of different sources of information on the decision to vaccinate. A cross-sectional study in Germany during the pandemic at the turn of the year 2021/2022.
    PLoS One. 2025;20:e0333268.
    PubMed         Abstract available
    
    
23. SEFAH IA, Ofori P, Hutton-Nyameaye A, Yamoah P, et al
    COVID-19 vaccine hesitancy and its predictors among healthcare workers in a tertiary hospital in Ghana: A cross-sectional survey.
    PLoS One. 2025;20:e0333412.
    PubMed         Abstract available
    
    
24. KUMAR D, Sagar V, Kujur A, Bhardwaj S, et al
    Identifying key predictors amongst children of under 5 years of age with fever and rashes amidst measles outbreak in Jharkhand: A case control study.
    PLoS One. 2025;20:e0333381.
    PubMed         Abstract available
    
    
25. CHAUFAN C
    How did Ontario healthcare institutions implement and legitimize Covid-19 vaccine mandates? A qualitative multi?method study protocol.
    PLoS One. 2025;20:e0332589.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

26. VILLAREJO-TORRES M, Nombela-Diaz I, Munoz-Santos D, Ruiz-Yuste M, et al
    SARS-CoV-2-derived RNA replicons as safe and effective vaccines.
    Proc Natl Acad Sci U S A. 2025;122:e2516587122.
    PubMed         Abstract available
    
    
27. MORIYAMA M, Rodrigues G, Wang J, Jayewickreme R, et al
    Intranasal hemagglutinin protein boosters induce protective mucosal immunity against influenza A viruses in mice.
    Proc Natl Acad Sci U S A. 2025;122:e2422171122.
    PubMed         Abstract available
    
    
28. REUBER EE, Hickey E, Pradhan A, Sprute R, et al
    Glycan microarray analysis of Candida-related antibodies in human and mice sera guides biomarker discovery and vaccine development.
    Proc Natl Acad Sci U S A. 2025;122:e2505340122.
    PubMed         Abstract available
    
    
29. LV H, Teo QW, Pholcharee T, Liu W, et al
    Molecular divergence and convergence of mammalian antibody responses to the influenza virus hemagglutinin stem.
    Proc Natl Acad Sci U S A. 2025;122:e2510927122.
    PubMed         Abstract available
    
    

    
    Vaccine

30. FANG X, Holding AC, Audet EC, Thai H, et al
    Understanding COVID-19 vaccination disparity among Black adults in North America: A two-study motivational approach.
    Vaccine. 2025;65:127803.
    PubMed         Abstract available
    
    
31. WROBLEWSKI M, Meler A
    Vaccine acceptance and refusal in Western and Central and Eastern European countries: An analysis based on the European Social Survey data from 23 countries, using a classification and regression tree.
    Vaccine. 2025;65:127807.
    PubMed         Abstract available
    
    
32. CLARKE M, McMillan M, Giles LC, Riley K, et al
    The impact of obesity on influenza Vaccine immunogenicity: A systematic review.
    Vaccine. 2025;65:127794.
    PubMed         Abstract available
    
    
33. DOMINGUEZ ISLAS CP, Magaret CA, Molitor C, Serebryannyy L, et al
    SARS-CoV-2 spike sequence-based distance as a marker of binding antibody response to COVID-19 vaccines.
    Vaccine. 2025;65:127738.
    PubMed         Abstract available
    
    
34. ZHANG CX, Quigley MA, Bankhead C, Varughese R, et al
    Ethnic inequities in childhood influenza vaccination coverage in England 2013-2021: An observational cohort study.
    Vaccine. 2025;65:127710.
    PubMed         Abstract available
    
    
35. CAMPBELL PM, Ess GJ, Lale A, Talaat KR, et al
    Clinical immunization safety assessment (CISA) project: COVID-19 vaccine consultations and case reviews.
    Vaccine. 2025;65:127781.
    PubMed         Abstract available
    
    
36. NOEL A, Zhang J, Nedumpun T, Sitthicharoenchai P, et al
    T cell-mediated clearance of porcine reproductive and respiratory syndrome virus (PRRSV) from the lung characterized by machine learning analysis in vaccinated and unvaccinated pigs.
    Vaccine. 2025;65:127793.
    PubMed         Abstract available
    
    
37. CHAUDHRY T, Tum P, Morrow F, Hargreaves S, et al
    Facilitators to strengthening vaccine uptake post-pandemic amongst underserved populations considering social norms and health beliefs: a global systematic review.
    Vaccine. 2025;65:127769.
    PubMed         Abstract available
    
    
38. CAO X, Borah P, Lee DKL, Vishnevskaya A, et al
    Beyond the post: The impact of politized anti-vaccine misinformation comments and challenges of correction on social media.
    Vaccine. 2025;65:127760.
    PubMed         Abstract available
    
    
39. ZEEVAT F, Luttjeboer J, Korsten K, van Boven M, et al
    Evaluating cost-effectiveness of RSV vaccination strategies for older adults in the Netherlands.
    Vaccine. 2025;65:127735.
    PubMed         Abstract available
    
    
40. ROSENBLUM HG, Carpenter CM, Trosclair T, Kaul R, et al
    Time intervals from vaccine administration to reimbursement for an updated Advisory Committee on Immunization Practices (ACIP) recommendation: Evidence from pneumococcal conjugate vaccinations among privately insured adults, 2021-2022.
    Vaccine. 2025;64:127665.
    PubMed         Abstract available
    
    
41. SCHUE JL, Miller ES, Fesshaye B, Singh P, et al
    Corrigendum to "COVID-19 vaccine attitudes, beliefs, intentions and behaviors among pregnant women within the context of dynamic national policy recommendations in Brazil, Ghana, Kenya, and Pakistan" [Vaccine (2025) 127595].
    Vaccine. 2025 Sep 25:127768. doi: 10.1016/j.vaccine.2025.127768.
    PubMed        
    
    
42. VAN SCHALKWYK C, Meyer-Rath G, Masuku S, Jamieson L, et al
    Cost-effectiveness of different HPV vaccination strategies for cervical cancer prevention in South Africa.
    Vaccine. 2025;64:127770.
    PubMed         Abstract available
    
    
43. CHO H, Jeong NY, Kim HJ, Lee HE, et al
    Intussusception risk after rotavirus vaccination in Korean infants.
    Vaccine. 2025;64:127782.
    PubMed         Abstract available
    
    
44. HWANG LE, Lin KY, Tseng PH, Ho SY, et al
    Impact of 10-year measles, mumps and rubella booster vaccination program among healthcare personnel: a cross-sectional study.
    Vaccine. 2025;64:127758.
    PubMed         Abstract available
    
    
45. VAN RIJN PA, Wernery U, Feddema AJ, Maris-Veldhuis MA, et al
    Development of African horse sickness disabled infectious single animal (DISA)-DIVA vaccine platform applied for all nine serotypes.
    Vaccine. 2025;64:127772.
    PubMed         Abstract available
    
    
46. PRZEDPELSKI A, Tepp WH, Gupta S, Barbieri JT, et al
    Nontoxic, multi-domain botulinum neurotoxin-LCHC(N) as vaccines against botulism.
    Vaccine. 2025;65:127779.
    PubMed         Abstract available
    
    
47. YANG Z, Zhang S, Zhao Y, Ma X, et al
    A mosaic H3 subtype live attenuated influenza vaccine elicits broad immune responses to influenza a viruses.
    Vaccine. 2025;65:127776.
    PubMed         Abstract available
    
    
48. ANWARI P, Sume G, Meshreky W, Maele NV, et al
    Health economics and vaccine financing in the eastern Mediterranean region: A needs assessment.
    Vaccine. 2025;65:127780.
    PubMed         Abstract available
    
    
49. BREZNIK JA, Miller MS, Bowdish DME
    Rationalizing recommendations for influenza and COVID-19 vaccines.
    Vaccine. 2025;65:127775.
    PubMed         Abstract available
    
    

    
    Virology

50. QIAO Y, Tang M, Du M, Zhao C, et al
    H5N1 influenza virus-like particles based on BEVS induce robust functional antibodies and immune responses.
    Virology. 2025;612:110672.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.